Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial

Trino Baptista, Nairy Rangel, Virginia Fernández et al. · Schizophrenia Research · 2007 · 136 citations

Medicine, Pharmacology, Psychiatry +12

A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain

David C. Henderson, Paul M. Copeland, Tara B. Daley et al. · American Journal of Psychiatry · 2005 · 125 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Weight loss in overweight patients maintained on atypical antipsychotic agents

Franca Centorrino, Judith J. Wurtman, Karen Duca et al. · International Journal of Obesity · 2006 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +16

Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome

Charles J. Glueck, D. Aregawi, M. Agloria et al. · Metabolism · 2006 · 37 citations

Medicine, Endocrinology, Gynecology +14

Pharmacotherapy of Obesity: Options and Alternatives

Ruben Buñag · Medicine & Science in Sports & Exercise · 2005 · 12 citations

Agriculture, Pharmacology, Pharmacotherapy +17